Chronic fatigue syndrome (CFS) is an illness characterized by profound fatigue lasting >6 months and accompanied by disturbances of sleep, neurocognition, mood, musculoskeletal pain, and other symptoms (reviewed in [1] ). It is a symptombased diagnosis of exclusion without distinguishing findings on physical examination or routine laboratory testing. In both clinical and community settings, CFS is reported most frequently among females. The clinical features of some cases of CFS, such as abrupt onset with fever, adenopathy, and influenza-like symptoms, in combination with epidemiologic studies consistent with outbreaks [2, 3] , have suggested that CFS may be the result of a virus infection or immune dysfunction and/or activation.
Although studies elsewhere have demonstrated T lymphocyte, B lymphocyte, or NK cell activation or dysfunction in some patients with CFS, results have been mixed both in terms of the frequency and types of abnormalities. In this study, our primary objectives were to investigate the relationship of CFS with T cell activation among 22 pairs of monozygotic twins discordant for CFS, using a co-twin study design to control for genetic and environmental factors not generally considered in typical casecontrol studies [4] .
Methods
Registry construction and subject recruitment. Twin pairs, in which 1 or both members reported persistent fatigue, were recruited for participation. Intake questionnaires were mailed to a total of 540 twins; of these, 398 (74%) were returned. To ascertain psychiatric conditions, the Diagnostic Interview Schedule Version III-A [5] , which assigns current and lifetime diagnoses, was administered by telephone to registry participants. Complete data were available for both members of 193 twin pairs. A more complete description of this volunteer twin registry can be found elsewhere [4] .
Selection of the clinical sample. From the twin registry, 22 sets of twins were chosen for a week-long in-person evaluation, on the basis of the intake questionnaire, the Diagnostic Interview Schedule, and additional telephone interviews and screening. Twins had to meet the following requirements: (1) be at least 18 years of age; (2) be monozygotic; (3) have been reared together; (4) be discordant for CFS (i.e., 1 twin met the Centers for Disease Control and Prevention criteria for CSF at the time of evaluation and the other twin was healthy); (5) discontinue alcohol, caffeine, and all medications known to affect immune or inflammatory function (i.e., nonsteroidal anti-inflammatory drugs and steroids) at least 2 weeks prior to and during the evaluation; and (6) travel to Seattle at the same time as their co-twin.
Of importance, the same inclusion and exclusion criteria (e.g., body-mass index and medical and psychiatric illness) and review processes were applied to the fatigued and healthy twin. All medical records for the past 5 years were requested and reviewed by an internist, a psychologist, and an infectious disease specialist for potentially exclusionary conditions. Just prior to the scheduled visit, the CFS symptom screening questions were re-administered to the ill twin to document that CFS criteria were still met, and the good health of the co-twin was confirmed. Nine additional pairs of monozygotic twins who were both healthy and nonfatigued were also studied, using the same protocol to determine the intra-twin pair variability for immune function in nondiseased twin pairs. Zygosity was initially determined using previously validated self-report methods [6] and then confirmed with analysis of restriction fragmentlength polymorphisms. By use of these methods, monozygosity can be determined with >0.999 certainty.
Lymphocyte subset analysis. Flow cytometric analyses were performed on fresh specimens as they were obtained. Specimens were obtained on the second day of the clinical evaluation to minimize the effects of travel stress, circadian dysrythymia, and specimen transport and collection variability on immune parameters [7] . All specimens were coded, and investigators and assay personnel were blinded to CFS status until all assays and analyses were completed.
An extensive 3-color flow cytometry panel was used to enumerate T lymphocytes, B lymphocytes, and NK cells in the peripheral blood and to study activation status of peripheral blood lymphocytes. The percentages of lymphocytes expressing various cell surface proteins were determined by staining peripheral blood mononuclear cells (PBMC) with mixtures of antibodies (table 1). Fluorescein isothiocyanate (FITC)-CD3/RD1-CD4 and FITC-CD3/RD1-CD8 were obtained from Coulter. All phycoerythrin (PE)-cyanin 5 tandem complex-conjugated antibodies, as well as FITC-CD57, PE-CD8, FITC-CD62L, PE-CD45RO, and PE-CD45RA, were obtained from Immunotech. PE-CD5, FITC-HLA-DR, and PE-CD25 were obtained from Becton-Dickinson. FITC-CD86 was obtained from PharMingen.
NK cell functional assay. NK cell activity was determined by use of a standard 4-h 51 Cr release assay, as described elsewhere [8] . Effector cells were PBMC purified from heparin-anticoagulated blood, by Ficoll-Hypaque density gradient centrifugation within 2 h of phlebotomy. Results were reported as lytic units/10 7 PBMC.
Statistical analysis. The mean levels of each lymphocyte marker combination in twins with CFS and healthy twins, along with the 95% confidence intervals for the mean differences between the twins with CFS and healthy twins in the discordant pairs, were estimated. The association of CFS with specific markers and NK activity was examined by using matched-pair t tests to assess statistical significance. To investigate whether the mechanism of CFS is a type of destabilization yielding an increase in variability of immunologic measures, F tests were used. The F tests compared the varibility of the differences in the measures between the fatigued and nonfatigued twins and the variability of the corresponding differences in the concordant twin pairs in which neither twin was fatigued. Bonferroni adjustments for multiple comparisons were based on the number of true null hypotheses estimated from P value plots [9] . Analyses were conducted using S-PLUS software (Insightful).
Results
Of the 193 twin pairs, 119 (62%) were discordant for at least 6 months of fatigue. Of these, 67 (56%) were monozygotic and had complete data available. Among these 67 monozygotic, chronic fatigue-discordant pairs, 14 were excluded for psychiatric illness, 4 for medical disorders, and 1 for a body mass index .45. In an additional 9 pairs, the fatigued twin did not meet CFS symptom criteria; 4 pairs were excluded because the nonfatigued twin had an exclusionary condition, and 6 pairs were excluded for other reasons (e.g., recent death of the cotwin, inadequate English, or pregnancy). This left 29 eligible twin pairs in which the ill twin met strict criteria for CFS and the co-twin was healthy and denied chronic fatigue. Of these 29 twin pairs, 22 (76%) completed the study, 1 (3%) refused, 2 (7%) could not be scheduled, and 4 (14%) were unable to discontinue potentially interfering medications.
The mean year of birth for the twin pairs was 1957 (mean age at the time of the study was 41.4 years). Twenty pairs were women, and all were white. There were no differences among the twins with CFS and the twins without CFS in the proportion who were married (59% vs. 59%), but there was a small, yet significant, difference for subjects with CFS versus subjects without CFS in the mean number of years of schooling (14.0 vs. 14.7, respectively; P < :01). The twins with CFS had an average duration of illness of 7.0 years and were first diagnosed with CFS at a mean age of 35 years.
Results of cell counts, 2-and 3-color immunophenotyping, and NK cell studies are summarized in table 2. Statistical significance at the P < :05 level was found for CD8 
CD45RA
2 cells (CFS , non-CFS, P ¼ :049). Patients with CFS had statisti- cally fewer CD4 + cells lacking the activation markers CD25 and HLA-DR (P ¼ :026). When a Bonferroni adjustment for multiple comparisons was applied to these data, no statistically significant differences were obtained for any of the variables tested.
The twin pairs discordant for CFS were compared with concordant twin pairs, in which both individuals were healthy and nonfatigued, to investigate whether CFS might result in an increase in variability of these immunologic measures. As determined by F tests, the 22 pairs of discordant twins exhibited significantly higher variability than the 9 pairs of concordant healthy twins for 20 of 48 measures examined, even after Bonferroni adjustment for multiple comparisons. 
CD45RO
+ (P ¼ :0037). In addition, there were significant differences for the expression of NK cell lytic units (P ¼ :0001) and total lymphocytes (P ¼ :0006).
Discussion
A growing literature on the association of T and NK cell immune perturbation or activation in CFS has been published over the last decade. In a study of 18 patients with CFS and 17 age-and sex-matched control subjects that used cryopreserved specimens and blinded testing, patients had a lower overall proportion of CD4 + T cells, a decrease in the percentage of CD4 + T cells bearing CD45RA (naive cells), and an increase in the percentage of CD8 + T cells bearing CD45RO (memory cells) [10] . Other investigators have reported increases in both CD4 + and CD8 + T cells expressing activation markers in CFS, including increased numbers of CD8 + T cells expressing HLA-DR [11] and CD4 + T cells expressing CD54 [10] . Conflicting results have been reported regarding NK cell numbers in CFS. All studies that reported NK cell activity assays noted a decrease in lytic activity [12] [13] [14] .
Intriguing as those findings are, they are counterbalanced by studies, including this one, reporting no differences in some or all of the specific parameters described above. Such disparities may be due to differences in data analysis or in selection of control groups, laboratory methods, or heterogeneity in the CFS populations studied. Age, sex, race, and HLA type have all been shown to influence phenotypic and functional assays used to measure T cell and NK cell activation and function [15] . Differences in control groups can also affect study results. For example, the mean percentage of CD8 + /HLA-DR + cells reported in controls varied greatly between studies, ranging from 1.5% to 14% [10, 11] . Similarly, the proportion of CD16 + NK cells expressing the activation marker HLA-DR in controls has varied from 1.1% to 3.0% of PBMC in 2 studies; moreover, the mean values for patients with CFS in these studies would be interpreted differently, depending on the values used for the control groups [11, 14] . Other confounding factors, such as methodologic issues in laboratory procedures (e.g., use of nonstandard whole blood NK cell activity assay) and differences in patient selection (e.g., including patients with various levels of disease severity), preclude rigorous comparisons between many studies.
In summary, in this co-twin control study of 22 monozygotic twin pairs discordant for CFS, we were unable to demonstrate significant immune perturbations in the twin affected by CFS. Studies of monozygotic, disease-discordant twins may more accurately identify immunologic similarities and differences in T cell and NK cell phenotype and function between subjects with CFS and healthy subjects than can traditional case-control designs since, at least for multiple sclerosis, data from monozygotic twins suggests a strong genetic contribution to the immune response [16] . In addition, because twin studies are especially well suited to the investigations of illnesses for which the appropriate comparison groups are not clearly defined [4] , they offer a unique approach for identifying factors associated with CFS.
